Medicalgorithmics S.A.

Regulatory Filings • Sep 24, 2025

Report Content Subject:One of the largest American IDTFs has increased by 118% the daily numberof ECG studies analyzed using Medicalgorithmics' proprietary software.

Date ofpreparation: 24 September 2025Legal basis: Article 17(1)of MAR - inside information

Report content:

With referenceto current report No. 2/2025 dated January 24, 2025, in whichMedicalgorithmics S.A., with its registered office in Warsaw ("Company";"Issuer"), informed about the conclusion of a significant agreement("Agreement") with a U.S.-based diagnostic center (IDTF, the "Partner"),and current report No. 18/2025 dated July 22, 2025, in which the Companyinformed the Partner's acceptance of the ECG software as provided in theAgreement and the commencement of use of the DeepRhythmPlatform (DRP)for the analysis of ECG studies, The Management Board ofMedicalgorithmics S.A. announces that, as of September 24 of this year,the Partner has increased the daily number of ECG studies analyzed usingthe leading DeepRhythmPlatform (DRP) software with DeepRhythmAI (DRAI)artificial intelligence algorithms by 118%. As a result, the Companywill already exceed the guaranteed minimum monthly compensation foranalyzed ECG studies in September of this year, and revenue under theAgreement with the Partner will grow faster than initially anticipatedby the Company.

As reported bythe Company in Current Report No. 2/2025, the guaranteed minimum monthlycompensation for analyzed sessions amounts to USD 60.8 thousand (approx.PLN 219.2 thousand according to the NBP exchange rate as of September23, 2025)